These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 556607)

  • 1. The heterogeneity of heparins.
    Lasker SE
    Fed Proc; 1977 Jan; 36(1):92-7. PubMed ID: 556607
    [No Abstract]   [Full Text] [Related]  

  • 2. The uses of degradative enzymes as tools for identification and structural analysis of glycosaminoglycans.
    Linker A; Hovingh P
    Fed Proc; 1977 Jan; 36(1):43-6. PubMed ID: 137129
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticoagulant activities of lung and mucous heparins.
    Barrowcliffe TW; Johnson EA; Eggleton CA; Thomas DP
    Thromb Res; 1978 Jan; 12(1):27-36. PubMed ID: 644557
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of analytical values for commerical heparin.
    Kavanagh LW; Jaques LB
    Arzneimittelforschung; 1973 Apr; 23(4):605-11. PubMed ID: 4740243
    [No Abstract]   [Full Text] [Related]  

  • 5. The nature of two components of pig mucosal heparin, separated by electrophoresis in agarose gel.
    Horner AA
    Can J Biochem; 1967 Jul; 45(7):1015-20. PubMed ID: 6035965
    [No Abstract]   [Full Text] [Related]  

  • 6. Electrofocusing of heparin: Presence of 21 monomeric and dimeric molecular species in heparin preparations.
    Dietrich CP; Nader HB; Mcduffie NN
    An Acad Bras Cienc; 1975; 47(2):301-9. PubMed ID: 1233886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro protamine neutralization profiles of heparins differing in source and molecular weight.
    Racanelli A; Hoppensteadt DA; Fareed J
    Semin Thromb Hemost; 1989 Oct; 15(4):386-9. PubMed ID: 2554498
    [No Abstract]   [Full Text] [Related]  

  • 8. Uronic acid composition of heparins and heparan sulfates.
    Taylor RL; Shively JE; Conrad HE; Cifonelli JA
    Biochemistry; 1973 Sep; 12(19):3633-7. PubMed ID: 4788306
    [No Abstract]   [Full Text] [Related]  

  • 9. Variability of heparin preparations in clinical use.
    Jaques LB; Kavanagh LW
    Thromb Diath Haemorrh Suppl; 1973; 56():171-80. PubMed ID: 4142115
    [No Abstract]   [Full Text] [Related]  

  • 10. Relative activities of heparin fractions obtained by gel chromatography.
    Graham DT; Pomeroy AR
    Thromb Haemost; 1980 Feb; 42(5):1598-603. PubMed ID: 7368160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The uronic acid composition of anticoagulantly active and inactive heparin.
    Rosenfeld L; Radoff S; Danishefsky I
    Arch Biochem Biophys; 1985 Nov; 242(2):574-8. PubMed ID: 4062296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The determination of iduronic acid and glucuronic acid in heparins by a new technique. Re-evaluation of the variable hexuronic acid composition of mammalian heparins.
    Inoue S
    Biochim Biophys Acta; 1973 Dec; 329(2):264-70. PubMed ID: 4797463
    [No Abstract]   [Full Text] [Related]  

  • 13. Anticoagulant activity of two commercially available heparin preparations. A controlled study.
    Gomez-Perez F
    J Clin Pharmacol New Drugs; 1972 Oct; 12(10):413-6. PubMed ID: 4484532
    [No Abstract]   [Full Text] [Related]  

  • 14. Fractionation and structural features of two heparin families with high antithrombotic, antilipemic and anticoagulant activities.
    Bianchini P; Osima B; Parma B; Nader HB; Dietrich CP; Casu B; Torri G
    Arzneimittelforschung; 1985; 35(8):1215-9. PubMed ID: 4074437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of anticoagulant activity of heparin].
    Dalmora SL; Assaf GS; Dalmora ME; Vaucher LC; Vaccari SF
    Rev Hosp Clin Fac Med Sao Paulo; 1991; 46(2):59-62. PubMed ID: 1843369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulant activity of whale intestine heparin and its clinical application.
    Abe T; Kazama M; Matsuda M; Ikemori R; Shibata T
    Bibl Haematol; 1968; 29():1141-9. PubMed ID: 5750138
    [No Abstract]   [Full Text] [Related]  

  • 17. Total glycosaminoglycan fraction from bovine aorta, intestinal mucosa & lungs on the concentration of lipids, plasma lipolytic activity & blood coagulation.
    Sherief PM; Sreekumar P; Sudhakaran PR; Kurup PA
    Indian J Exp Biol; 1978 Feb; 16(2):218-21. PubMed ID: 680816
    [No Abstract]   [Full Text] [Related]  

  • 18. Rapid molecular size characterization of heparins by high pressure liquid chromatography.
    Sugisaka N; Petracek FJ
    Fed Proc; 1977 Jan; 36(1):89-92. PubMed ID: 556606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics of heparin. II. Chromatographic behavior and biologic activity].
    Ferrari L; Boffi C
    Farmaco Prat; 1970 Feb; 25(2):130-41. PubMed ID: 5515618
    [No Abstract]   [Full Text] [Related]  

  • 20. Differentiation of beef and pig mucosal heparins by NMR spectroscopy.
    Casu B; Guerrini M; Naggi A; Torri G; De-Ambrosi L; Boveri G; Gonella S; Ronzoni G
    Thromb Haemost; 1995 Oct; 74(4):1205. PubMed ID: 8560442
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.